Skip to content

Drug interactions

Crizotinib + Lenacapavir

Severity: Moderate

Crizotinib and Lenacapavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor and may increase crizotinib concentrations, with effects persisting for months after the last subcutaneous dose. Higher crizotinib exposure raises the risk of QT prolongation, hepatotoxicity and bradycardia.

What this interaction means in plain words

Crizotinib and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Crizotinib belongs to Oncology; Lenacapavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition by lenacapavir reduces crizotinib metabolism.

What to do

Monitor ECG, heart rate and liver tests, and consider crizotinib dose reduction if adverse effects emerge. Remember the inhibitory effect may persist long after lenacapavir dosing.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Lenacapavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Lenacapavir?

MediHelp rates the interaction as moderate. Crizotinib and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor and may increase crizotinib concentrations, with effects persisting for months after the last subcutaneous dose. Higher crizotinib exposure raises the risk of QT prolongation, hepatotoxicity and bradycardia.

How serious is the interaction between Crizotinib and Lenacapavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG, heart rate and liver tests, and consider crizotinib dose reduction if adverse effects emerge. Remember the inhibitory effect may persist long after lenacapavir dosing.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in